UNIVERSITE DE MONTPELLIER
Patent Owner
Stats
- 31 US PATENTS IN FORCE
- 16 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 31 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 676 Total Citation Count
- Sep 06, 2004 Earliest Filing
- 10 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0239,237 PYRROLOQUINOLINE DERIVATIVES AS 5-HT6 ANTAGONISTS, PREPARATION METHOD AND USE THEREOFMay 05, 17Aug 24, 17[A61K]
2017/0211,151 METHODS FOR PREDICTING RESPONSE TO DNA REPAIR PATHWAY INHIBITORS IN DIFFUSE LARGE B-CELL LYMPHOMAJul 27, 15Jul 27, 17[C12Q, G06F]
2017/0197,938 A QUINOLINE DERIVATIVE FOR THE TREATMENT OF INFLAMMATORY DISEASES AND AIDSJul 17, 15Jul 13, 17[C07D]
2017/0183,742 METHODS FOR PREDICTING THE SURVIVAL TIME OF PATIENTS SUFFERING FROM CANCERMay 27, 15Jun 29, 17[C12Q]
2017/0110,611 MULTIPLE-JUNCTION PHOTOVOLTAIC CELL BASED ON ANTIMONIDE MATERIALSMay 20, 15Apr 20, 17[H01L]
2017/0096,710 METHODS FOR PREDICTING RESPONSE TO HDACI/DNMTI COMBINATION IN MULTIPLE MYELOMAMar 20, 15Apr 06, 17[A61K, C12Q, G06F]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9890112 Compounds for use as therapeutic agents affecting p53 expression and/or activityApr 02, 12Feb 13, 18[A61K, C07D, C07C]
9774165 Vertical external cavity surface emitting laser devices allowing high coherence, high power and large tunabilityMay 21, 15Sep 26, 17[H01S]
9765339 FLT3 receptor antagonists for the treatment or the prevention of pain disordersJul 08, 15Sep 19, 17[A61K, C07H, C12N, G01N, C07K]
9688990 Methods and pharmaceutical compositions for treatment of cystic fibrosisSep 12, 14Jun 27, 17[A61K, C12N]
9611481 Chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereofSep 23, 10Apr 04, 17[A61K, C12Q, C12N, G01N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0083,712 CSN5 POLYPEPTIDES AND USES THEREOF FOR SCREENING THERAPEUTIC AGENTSAbandonedOct 14, 13Mar 24, 16[C12N, G01N]
2015/0376,216 SUGAR-ANALOG PHOSPHORUS-CONTAINING HETEROCYCLES HAVING AN ANTI-METASTATIC ACTIVITYAbandonedFeb 25, 14Dec 31, 15[A61K, C07F]
2015/0297,573 TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING Beta-CELL SURVIVALAbandonedOct 24, 13Oct 22, 15[A61K]
2015/0259,403 Methods and Pharmaceutical Compositions for Treatment of Gastrointestinal Stromal TumorsAbandonedOct 10, 13Sep 17, 15[A61K, C12Q, G01N, C07K]
2015/0037,282 D-AMINO ACID PHOSPHORAMIDATE PRONUCLEOTIDES OF HALOGENO PYRIMIDINE COMPOUNDS FOR LIVER DISEASEAbandonedJul 31, 14Feb 05, 15[C07H, A61K]
2014/0148,363 Methods for Selecting Oocytes and Competent Embryos with High Potential for Pregnancy OutcomeAbandonedJan 30, 14May 29, 14[C12Q]
8067338 Trichloro silyl alkyl isocyanate molecule and surface modified mineral substrateExpiredNov 28, 05Nov 29, 11[C07F, C40B]
2008/0279,855 Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical CompositionsAbandonedSep 22, 04Nov 13, 08[A61K, C12N, A61P, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
